Evidence map›Paper›PMID 26135565›Full record

SynthesisPloS one2015

Interrelationships between Atopic Disorders in Children: A Meta-Analysis Based on ISAAC Questionnaires.

David H J Pols, Jorien B Wartna, Elvira I van Alphen, Heleen Moed, Nadine Rasenberg, Patrick J E Bindels, Arthur M Bohnen

Abstract readMeta-Analysis
In one paragraph

Synthesis in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Total IgE Trends in Children with Allergic Diseases.Journal of clinical medicine · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Bioinformatics Analysis and Identification of Underlying Biomarkers Potentially Linking Allergic Rhinitis and Asthma.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  18. Article
  19. How a farming environment protects from atopy.Current opinion in immunology · 2019
    Review
  20. Effects of loratadine, a histamine HDrug design, development and therapy · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David H J PolsDepartment of General Practice, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Jorien B WartnaDepartment of General Practice, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Elvira I van AlphenDepartment of General Practice, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Heleen MoedDepartment of General Practice, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Nadine RasenbergDepartment of General Practice, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Patrick J E BindelsDepartment of General Practice, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Arthur M BohnenDepartment of General Practice, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo study the prevalence and interrelationship between asthma, allergic rhinitis and eczema using data obtained from ISAAC questionnaires.

methodThe Medline, Pubmed Publisher, EMBASE, Google Scholar and the Cochrane Controlled Clinical Trials Register databases were systematically reviewed to evaluate epidemiological data of children with atopic disorders. To study these interrelationships, a new approach was used. Risk ratios were calculated, describing the risk of having two different atopic disorders when the child is known with one disorder.

resultsIncluded were 31 studies, covering a large number of surveyed children (n=1,430,329) in 102 countries. The calculated worldwide prevalence for asthma, eczema and allergic rhinitis is 12.00% (95% CI: 11.99-12.00), 7.88% (95% CI: 7.88-7.89) and 12.66% (95% CI: 12.65-12.67), respectively. The observed prevalence [1.17% (95% CI: 1.17-1.17)] of having all three diseases is 9.8 times higher than could be expected by chance. For children with asthma the calculated risk ratio of having the other two disorders is 5.41 (95% CI: 4.76-6.16), for children with eczema 4.24 (95% CI: 3.75-4.79), and for children with allergic rhinitis 6.20 (95% CI: 5.30-7.27). No studied confounders had a significant influence on these risk ratios.

conclusionsOnly a minority of children suffers from all three atopic disorders, however this co-occurrence is significantly higher than could be expected by chance and supports a close relationship of these disorders in children. The data of this meta-analysis supports the hypothesis that there could be a fourth distinct group of children with all three disorders. Researchers and clinicians might need to consider these children as a separate group with distinct characteristics regarding severity, causes, treatment or prognosis.

Indexed as

AdolescentAlgorithmsAsthmaChildChild, PreschoolClinical Trials as TopicComorbidityDatabases, FactualEczemaFemaleHumansInfantInfant, NewbornMaleModels, StatisticalPrevalence

Identifiers

PMID26135565
PMCPMC4489894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.